The Iranian pharmaceutical industry has witnessed significant transformations in recent years. The head of the Syndicate of Pharmaceutical Raw Material, Chemical, and Packaging Producers stated that the country has succeeded in producing about 700 out of 900 pharmaceutical active ingredients available worldwide, highlighting notable achievements in pharmaceutical infrastructure.
Significant Advances in Domestic Production
This achievement demonstrates Iran's serious commitment to reducing dependence on imports and developing self-sufficiency in the production of necessary medications. According to the head of the syndicate, given the existing capacities, Iran is capable of not only meeting domestic needs but also exporting to international markets.
The head of the syndicate also pointed out the challenges ahead in this industry and emphasized the need for government and relevant institutions' support to increase production and improve quality. He added: "We must focus on research and development to produce the most up-to-date and highest quality raw materials."
Bright Prospects for the Pharmaceutical Industry
This growth in the production of pharmaceutical raw materials is particularly significant given that the country is facing sanctions and international restrictions. Experts believe that these successes can greatly contribute to improving health and treatment conditions in the country.
Ultimately, with these achievements, Iran's pharmaceutical industry has taken significant steps towards independence and self-sufficiency, promising that we will witness a remarkable transformation in the field of medicine and treatment in the near future.
